Multi-center Study on Comprehensive Diagnosis and Treatment of Lower Limb Bone Defect Based on Three-dimensional Printing Technology
1 other identifier
observational
120
1 country
1
Brief Summary
The clinical diagnosis and treatment of lower limb bone defect is a difficult problem in orthopedics. The traditional treatment has the shortcomings of long treatment period, no weight bearing in the early stage of the limb, weak mechanical strength, many complications, and difficulty in repairing deformed and large segment bone defects around the joint. The Orthopedics Department of Peking University Third Hospital, the lead unit of this study, developed the TCBridge system based on three-dimensional (3D) printing technology in the early stage, which is the first approved 3D printing lower limb long bone defect repair system in China. The system can achieve personalized and accurate repair of lower limb bone defects, and ensure patients to carry out limb weight and functional exercise safely in the early stage after surgery. On this basis, this study will establish a multi-center clinical case cohort to achieve accurate comprehensive diagnosis and treatment of lower limb bone defects, benefiting patients and contributing to society.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2023
Typical duration for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2023
CompletedFirst Submitted
Initial submission to the registry
December 18, 2023
CompletedFirst Posted
Study publicly available on registry
February 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2026
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 31, 2026
February 21, 2024
November 1, 2023
2.6 years
December 18, 2023
February 20, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Evaluation of implant stability, new bone growth- limb length
X-ray X、CT images
post-operative 1.3.6.12.24.36 months
Evaluation of bone healing
computed tomography (CT)
post-operative 3.6.12.24.36 months
Secondary Outcomes (5)
Pain assessment
post-operative 1.3.6.12.24.36 months
Evaluation of life quality and health status.
post-operative 1.3.6.12.24.36 months
Evaluation of knee function
post-operative 1.3.6.12.24.36 months
Evaluation of hip function
post-operative 1.3.6.12.24.36 months
Evaluation of ankle function
post-operative 1.3.6.12.24.36 months
Study Arms (3)
Traumatic bone defect in lower limb
Traumatic bone defect in lower limb
Infective lower limb bone defect
Infective lower limb bone defect
Neoplastic bone defect in lower limb
Neoplastic bone defect in lower limb
Interventions
3D printed prostheses
Eligibility Criteria
Patients with lower limb defects
You may qualify if:
- Patients with traumatic lower limb bone defect;
- Infected lower limb bone defect patients;
- Patients with neoplastic lower limb bone defect;
- The above reasons caused bone defects of more than 5CM
- at least 18 years of age;
- Sign an informed agreement and join the study cohort voluntarily.
You may not qualify if:
- Patients who do not agree to the use of 3D printed microporous titanium alloy prostheses;
- Patients who cannot tolerate surgery;
- the subjects cannot comply with the follow-up or affect the scientific and integrity of the study;
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Peking University Third Hospital
Beijing, Haidian, China
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Target Duration
- 3 Years
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
December 18, 2023
First Posted
February 21, 2024
Study Start
November 1, 2023
Primary Completion (Estimated)
June 1, 2026
Study Completion (Estimated)
December 31, 2026
Last Updated
February 21, 2024
Record last verified: 2023-11
Data Sharing
- IPD Sharing
- Will not share